Agents of Bioterrorism

Slide 1 · Agents of Bioterrorism

Pathologic mechanisms · characteristic lesions · public health implications

An integrated infectious disease lecture

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain the risk-based A/B/C framework used in the supplied Robbins section.

Relate selected Category A agents to distinctive pathologic lesions and organ injury.

Contrast anthrax, plague, viral hemorrhagic fever, and orthopoxvirus disease.

Apply the Category B and C examples to surveillance and clinical interpretation.

Slide 3 · What the term bioterrorism denotes

It as the use of biologic or chemical agents as weapons.

For infectious agents, classification concerns their capacity to threaten populations.

The textbook organizes potential biologic agents into risk-based Categories A, B, and C.

The lecture examines pathology and recognition rather than mechanisms of deliberate dissemination.

Slide 4 · Why potential agents are risk-stratified

Potential public health threat

Capacity for spread / exposure

Expected disease burden

Preparedness requirements

This is a conceptual synthesis of the criteria; It is not a quantitative risk score.

Slide 5 · Three-category framework at a glance

Category

Textbook risk profile

Representative examples

A

Highest threat; Major mortality and public concern

Smallpox; Anthrax; Plague; Hemorrhagic fever viruses

B

Moderate morbidity, lower mortality; Diagnostic surveillance

Brucella spp.; Vibrio cholerae

C

Emerging threats; Potential major future impact

Hantavirus; Nipah virus

Slide 6 · Threat classification is not a diagnosis

Risk classification asks

How consequential could a population event be?

What level of preparedness or surveillance is needed?

Which pathogens warrant additional attention?

Clinical pathology asks

Which organ systems are injured?

What mechanism explains the lesion?

What findings differentiate plausible etiologies?

Slide 7 · Category A: Defining features

Described as the highest-risk group.

Potential for ready dissemination or interpersonal transmission.

Potential for high mortality, broad public concern, and emergency preparedness needs.

Includes bacterial infections, orthopoxvirus disease, and viral hemorrhagic fever viruses.

Slide 8 · Category A: Organism-to-syndrome map

Illustrative agent

Dominant syndrome

Pathologic focus

B. Anthracis

Cutaneous, inhalational, or gastrointestinal anthrax

Edema, necrosis, hemorrhagic mediastinitis

Y. Pestis

Bubonic, pneumonic, or septicemic plague

Necrotic nodes, hemorrhagic pneumonia, DIC

Variola virus

Smallpox (eradicated naturally)

High transmissibility and population susceptibility

Hemorrhagic fever viruses

Multisystem infection

Vascular injury, coagulopathy, shock

Slide 9 · Smallpox in the Category A rationale

High transmissibility and historical severe mortality.

Naturally occurring smallpox was eradicated worldwide in 1980.

Cessation of routine vaccination left population immunity diminished.

Its placement illustrates how susceptibility and transmission affect threat assessment.

Slide 10 · Vaccination history and susceptible populations

Naturally occurring smallpox eradicated

Routine vaccination discontinued

Population immunity wanes

Public health preparedness concern

Historical facts from the source; This schematic does not represent a current vaccination recommendation.

Slide 11 · Smallpox and mpox: Related, not identical

Smallpox (variola)

Eradicated as a naturally occurring infection.

No animal reservoir described in the chapter.

Named as a Category A example.

Mpox

A related orthopoxvirus with zoonotic reservoirs.

Causes evolving skin and mucosal lesions.

Morphology offers a model for poxvirus tissue injury.

Slide 12 · Poxvirus pathology: An instructive parallel

Mpox eruptions may progress from macules and papules to vesicles and pustules.

Epidermal necrosis and ballooning keratinocytes are described histologically.

Cytoplasmic Guarnieri inclusions may be present.

These mpox findings provide context, not a substitute for direct variola histopathology.

Slide 13 · Anthrax: Pathogen and tissue injury

Bacillus anthracis is a large, spore-forming gram-positive rod.

Naturally acquired disease is associated with infected animals and their products.

Lesions involve necrosis with an exudative inflammatory response.

The principal clinical forms are cutaneous, inhalational, and gastrointestinal.

Slide 14 · Anthrax: Clinical form determines anatomy

Form

Typical clinical picture

Pathologic emphasis

Cutaneous

Painless papule → vesicle → black eschar

Dermal lesion with striking edema

Inhalational

Prodrome → abrupt hypoxia, systemic illness

Hemorrhagic mediastinitis and lymphadenitis

Gastrointestinal

Abdominal symptoms, possible bloody diarrhea

Necrotizing gastrointestinal injury

Slide 15 · Cutaneous anthrax: Lesion evolution

Pruritic, painless papule

Vesicle with surrounding edema

Ulceration

Characteristic black eschar

The severe regional edema helps distinguish the characteristic lesion from an ordinary superficial pustule.

Slide 16 · Why cutaneous anthrax produces an eschar

The organism induces necrotizing inflammation in affected tissue.

Exudation and edema surround the evolving primary lesion.

Ulceration leaves a dark necrotic surface crust, the black eschar.

Regional lymphadenopathy may accompany the cutaneous lesion.

Slide 17 · Inhalational anthrax: Anatomic progression

Respiratory exposure

Phagocyte transport to regional nodes

Bacterial growth and toxin injury

Hemorrhagic mediastinitis

Emphasis: Mediastinal and lymph-node injury, rather than primary destructive airway infection.

Slide 18 · Inhalational anthrax: Clinical transition

Initial symptoms may include fever, cough, and chest or abdominal pain.

Deterioration can be abrupt, with worsening fever, hypoxia, and sweating.

Bacteremia may lead to meningitis and systemic shock.

The severe course reflects profound toxin-associated and vascular injury.

Slide 19 · Hemorrhagic mediastinitis: Major lesion

The mediastinum may contain multiple hemorrhagic foci.

Hilar and peribronchial nodes show hemorrhagic lymphadenitis.

Edema expands affected lymph nodes.

The distribution provides an anatomically useful clue to inhalational anthrax.

Slide 20 · Inhalational anthrax: Pulmonary morphology

Perihilar interstitial pneumonia.

Macrophages and neutrophils infiltrate involved lung tissue.

Vasculitis and associated hemorrhagic lung lesions may occur.

The degree of alveolar involvement can differ from the dominant mediastinal pattern.

Slide 21 · Systemic anthrax: Dissemination and organ damage

Local infection / lymph-node disease

Bacteremia

Vascular and inflammatory injury

Multiorgan involvement

Fatal infections may involve meninges and multiple visceral organs.

Slide 22 · Gastrointestinal anthrax

Natural infection is associated with contaminated animal-derived food.

Nausea, abdominal pain, and vomiting may precede severe bloody diarrhea.

The pathologic process is necrotizing and may become systemic.

This form must be distinguished from toxin-mediated noninvasive secretory diarrhea.

Slide 23 · Microscopy: Recognizable anthrax clues

Necrosis with an exudate containing neutrophils and macrophages.

Large, boxcar-shaped gram-positive extracellular bacilli may appear in chains.

Brown and Brenn staining or culture as supportive evidence.

Morphology alone is not a substitute for definitive microbiologic identification.

Slide 24 · Anthrax toxin: Three separate components

Component

Primary role

Cellular consequence

Protective antigen (PA)

Cell binding and delivery platform

Permits EF or LF entry

Edema factor (EF)

Calmodulin-dependent adenylate cyclase

Increases intracellular cAMP

Lethal factor (LF)

Protease affecting MAPKK and PI3K regulators

Disturbs signaling and contributes to cell injury

Slide 25 · Anthrax toxins: Shared entry, distinct effects

PA associates with cell receptor

EF or LF joins PA complex

Complex enters host cell

EF or LF acts in cytoplasm

The protective antigen is a delivery component; EF and LF produce different biochemical effects.

Slide 26 · Edema factor: Biochemical route to edema

Edema factor inside cell

Calmodulin-dependent cyclase activity

Intracellular cAMP rises

Altered cell function / edema

This molecular mechanism helps explain the clinically striking edematous component.

Slide 27 · Lethal factor: Signaling disruption

Lethal factor enters cytoplasm

Proteolytic effects on signaling regulators

MAPKK / PI3K pathways disrupted

Cell injury and death

The precise mechanism linking pathway disruption to cell death is unresolved.

Slide 28 · Anthrax virulence: Capsule versus toxins

Polyglutamyl capsule

Antiphagocytic surface feature.

Promotes persistence in host tissues.

Interferes with an important host-defense process.

Toxin components

PA supports intracellular delivery.

EF increases cAMP.

LF perturbs regulatory signaling.

Slide 29 · Anatomic differential among anthrax forms

Feature

Cutaneous

Inhalational

Gastrointestinal

Primary compartment

Skin

Regional thoracic nodes / mediastinum

Intestinal tract

Signature clue

Edematous black eschar

Hemorrhagic mediastinitis

Abdominal illness / bleeding

Potential complication

Regional lymphadenopathy

Meningitis, shock

Bacteremia

Slide 30 · Case: Progressive black eschar

Clinical–pathologic vignette

A patient develops a painless, pruritic papule followed by vesiculation, impressive regional edema, and a black surface crust.

What pathogen and lesion mechanism best explain this constellation?

Slide 31 · Case interpretation: Cutaneous anthrax

The painless evolving lesion with edema and black eschar is characteristic.

B. Anthracis produces necrotizing inflammation and important toxin-mediated effects.

A true clinical workup requires appropriate laboratory and public health procedures.

The syndrome alone does not establish whether exposure was natural or intentional.

Slide 32 · Plague: Etiologic and pathologic identity

Yersinia pestis is a gram-negative, facultatively intracellular bacterium.

A zoonotic infection involving mammalian reservoirs.

It may spread to lymph nodes, lungs, and the bloodstream.

Early recognition is important because antimicrobial treatment can be effective.

Slide 33 · Plague: Three major clinicopathologic patterns

Pattern

Dominant site

Defining process

Bubonic

Draining lymph nodes

Massive enlargement; Necrosis

Pneumonic

Lungs and pleura

Hemorrhagic necrotizing bronchopneumonia

Septicemic

Bloodstream and multiple organs

DIC, infarction and hemorrhage

Slide 34 · Plague: Tissue spread and host response

Initial infection

Regional lymphoid involvement

Intracellular bacterial persistence

Necrosis and hemorrhage

The pattern reflects both bacterial multiplication and impaired early host defenses.

Slide 35 · Yersinia pestis: Immune interference

The bacterium uses a type III secretion system.

Yop proteins disrupt host phagocytic machinery.

Additional effects reduce inflammatory cytokine signaling.

This provides a mechanism for prominent early bacterial proliferation in tissues.

Slide 36 · Bubonic plague: Distinctive lymph-node lesion

Draining lymph nodes enlarge markedly and may become pulpy and plum-colored.

Tissue necrosis and vascular damage coexist with edema.

Neutrophilic inflammation becomes conspicuous near necrotic tissue.

These swollen nodes are called buboes.

Slide 37 · Pneumonic plague: Morphology

Described as confluent hemorrhagic and necrotizing bronchopneumonia.

Fibrinous pleuritis may accompany the parenchymal lesion.

The pulmonary form differs from the primarily mediastinal pathology of inhalational anthrax.

Respiratory transmission is clinically relevant for pneumonic disease.

Slide 38 · Septicemic plague: Vascular complications

Disseminated infection can cause necrotic foci in multiple organs.

Fulminant bacteremia may trigger disseminated intravascular coagulation.

Widespread thrombi and hemorrhages reflect the microvascular process.

These findings must be interpreted with the full infectious differential.

Slide 39 · Plague versus inhalational anthrax

Feature

Pneumonic plague

Inhalational anthrax

Dominant thoracic lesion

Necrotizing bronchopneumonia

Hemorrhagic mediastinitis

Characteristic nodes

Regional/systemic necrotizing lymphadenitis

Thoracic hemorrhagic lymphadenitis

Prominent systemic injury

Septicemia, DIC

Toxin-associated shock; Possible meningitis

Slide 40 · Viral hemorrhagic fever: Syndrome definition

A severe multisystem syndrome associated with vascular injury.

Clinical severity ranges from febrile illness to shock.

Hemorrhage can result from several interlocking mechanisms.

Pathology often combines vascular dysfunction with organ-specific necrosis.

Slide 41 · Hemorrhagic fever viruses: Textbook groups

Virus family / order

Illustrative disease context

Arenaviridae

Lassa fever

Filoviridae

Ebola and Marburg virus disease

Bunyavirales

Crimean–Congo hemorrhagic fever

Flaviviridae

Hemorrhagic syndromes in relevant flaviviral infection

Slide 42 · Hemorrhagic fever: Clinical severity spectrum

Early manifestations can include fever, headache, myalgia, and rash.

Neutropenia and thrombocytopenia may be observed.

Severe illness progresses to hemodynamic deterioration and shock.

Hemorrhage is variable and is not equally prominent in every syndrome.

Slide 43 · Viral hemorrhagic fever: Vascular injury

Viral infection of target cells

Endothelial / myeloid-cell injury

Inflammatory mediator release

Vascular dysfunction and shock

Direct endothelial injury and cytokine-mediated mechanisms as possibilities across different viruses.

Slide 44 · Four contributors to hemorrhage

Platelet reduction / dysfunction

Endothelial injury

Cytokine-associated DIC

Hepatic clotting-factor deficiency

Different contributions dominate in different infections; No single mechanism explains all cases.

Slide 45 · Viral hemorrhagic fever: Tissue morphology

Focal to extensive tissue necrosis can accompany vascular injury.

The inflammatory response may be surprisingly sparse.

Petechial hemorrhage reflects combined platelet and vascular abnormalities.

A hemorrhagic phenotype is not specific for a single viral family.

Slide 46 · Ebola infection: Organ patterns

Viral replication and hemorrhagic injury can involve multiple organs.

The liver may show hepatocellular necrosis with scant inflammation.

The spleen may exhibit lymphocyte apoptosis.

Dendritic cells, fibroblasts, and monocytes can be sites of viral replication.

Slide 47 · Ebola: Two interferon-antagonist proteins

VP24

Inhibits STAT1 nuclear translocation.

Interferes with type I interferon responses.

Supports viral immune evasion.

VP35

Interferes with type I interferon signaling.

Can bind double-stranded viral RNA.

Limits RIG-I–dependent recognition.

Slide 48 · Necrosis and hemorrhage: Different mechanisms

Syndrome

Dominant pathologic driver

Characteristic manifestation

Anthrax

Bacterial toxin-associated vascular/inflammatory injury

Hemorrhagic mediastinitis

Plague

Invasive bacterial proliferation and vascular necrosis

Buboes, pneumonia, DIC

Viral hemorrhagic fever

Endothelium, platelets, coagulation, cytokines

Multisystem hemorrhage / shock

Slide 49 · Category B: Organizing principle

Moderately high concern but lower stated mortality than Category A.

Some examples are associated with food- or water-borne transmission.

Specific diagnostic capability and disease surveillance are central.

Brucella spp. And Vibrio cholerae as representative agents.

Slide 50 · Category B examples: Different clinical syndromes

Brucella spp.

as a Category B example.

Bacterial rather than viral agent.

Its inclusion illustrates the breadth of the category.

Vibrio cholerae

Cited as a Category B example.

Causes potentially severe secretory diarrhea.

Watery diarrhea is due to enterotoxin physiology.

Slide 51 · Cholera: Source and typical spread

Vibrio cholerae is a comma-shaped, gram-negative bacterium.

Contaminated drinking water as a major route.

Damaged sanitation systems can amplify waterborne outbreaks.

The primary disease process is intestinal fluid secretion, not bacterial invasion.

Slide 52 · Cholera toxin: Secretory pathogenesis

Intestinal colonization

Cholera toxin acts on enterocyte signaling

CAMP-dependent CFTR activation

Fluid and electrolyte secretion

The organism remains predominantly within the lumen; Epithelial signaling drives the major clinical effect.

Slide 53 · Cholera: Morphology can be deceptively mild

Vibrio organisms are described as noninvasive in the supplied section.

The secretory mechanism results in profound water loss.

Mucosal biopsy can show minimal structural alteration.

Severe physiologic dysfunction therefore does not require deep necrotizing injury.

Slide 54 · Cholera versus gastrointestinal anthrax

Question

Cholera

Gastrointestinal anthrax

Dominant mechanism

Enterotoxin-driven secretion

Necrotizing infection

Typical stool pattern

Profuse watery diarrhea

May develop bloody diarrhea

Mucosal tissue injury

Minimal histologic changes

Necrotizing inflammatory lesions

Major immediate threat

Dehydration and shock

Bleeding, bacteremia and shock

Slide 55 · Cholera: Clinical correlation

Severe cases may develop abundant “rice-water” diarrhea and vomiting.

Dehydration leads to hypotension, anuria, shock, and impaired consciousness.

Timely fluid replacement is the central life-saving measure.

The syndrome illustrates why public health surveillance matters for Category B.

Slide 56 · Brucella spp.: Scope of the provided text

Brucella species are explicitly listed as Category B examples.

The supplied bioterrorism subsection does not describe their distinctive lesions.

Therefore, no unsupported morphology or laboratory criteria are assigned here.

This is a deliberate boundary between the source-backed category and unverified disease detail.

Slide 57 · Category C: Emerging-pathogen concept

Concern centers on emerging agents with potentially large future effects.

Availability, possible spread, and potential morbidity/mortality.

The category is anticipatory: A future threat is not the same as a current outbreak.

Robbins gives hantavirus and Nipah virus as illustrative agents.

Slide 58 · Category C exemplars in the source

Hantavirus

Listed by name in Category C.

The excerpt does not detail the specific syndrome.

Do not extrapolate a diagnostic phenotype from classification alone.

Nipah virus

Listed by name in Category C.

The excerpt does not specify mechanisms or pathology.

Further disease-specific instruction needs verified sources.

Slide 59 · What the A/B/C labels do—and do not—encode

Category

Primary textbook emphasis

Not established by the letter alone

A

Greatest immediate risk and preparedness concerns

Specific diagnosis in an individual

B

Diagnostic / surveillance burden

Necessarily mild illness in every patient

C

Potential future emergence and impact

Current geographic incidence or active release

Slide 60 · From disease pattern to public health response

Recognize a characteristic syndrome

Correlate with tissue / microbiology

Engage appropriate clinical systems

Support surveillance / preparedness

The sequence is a clinical teaching framework, not a release-detection protocol or a substitute for institutional guidance.

Slide 61 · Why morphology matters in preparedness

The same public health category can contain agents with very different lesions.

Hemorrhagic mediastinitis points toward a different differential than watery diarrhea.

Necrotizing lymphadenitis and diffuse vascular injury require different diagnostic reasoning.

Pathology supplies mechanism-specific information without establishing intentionality.

Slide 62 · Case: Thoracic lymph nodes and hemorrhage

Clinical–pathologic vignette

A patient with systemic collapse has prominent mediastinal hemorrhage and enlarged hemorrhagic hilar lymph nodes. Lung lesions are predominantly perihilar.

Which Category A disease pattern is most compatible, and which tissue distribution supports it?

Slide 63 · Case interpretation: Inhalational anthrax

Hemorrhagic mediastinitis is the major anatomic clue.

Hemorrhagic hilar and peribronchial lymphadenitis strengthens that pattern.

Pneumonic plague more strongly features necrotizing bronchopneumonia.

A specific laboratory diagnosis and exposure assessment remain essential.

Slide 64 · Case: Profound diarrhea with limited mucosal injury

Clinical–pathologic vignette

A patient has severe watery diarrhea, hypotension, and a relatively unremarkable intestinal mucosal biopsy.

Why can a serious Category B infection have little histologic destruction?

Slide 65 · Case interpretation: Secretory physiology

Cholera toxin disrupts epithelial ion transport through cAMP signaling.

Large-scale electrolyte and water secretion can occur without bacterial tissue invasion.

Minimal mucosal alteration does not exclude life-threatening fluid loss.

Management focuses on rapidly correcting the resulting physiologic deficit.

Slide 66 · High-yield clinicopathologic contrasts

Finding

Most relevant teaching example

Reason

Black eschar with extensive edema

Cutaneous anthrax

Necrotizing toxin-associated lesion

Hemorrhagic mediastinitis

Inhalational anthrax

Thoracic lymph-node and vascular injury

Necrotizing bubo

Bubonic plague

Regional Yersinia proliferation / necrosis

Hemorrhage with scant inflammation

Viral hemorrhagic fever

Vascular/coagulation injury

Profuse watery stool, preserved mucosa

Cholera

Enterotoxin-induced secretion

Slide 67 · Integrated conclusions

The A/B/C framework classifies potential public health impact, not histologic appearances.

Category A encompasses sharply different pathogen mechanisms and tissue patterns.

Category B cholera exemplifies severe functional dysfunction with minimal mucosal injury.

Category C highlights emerging threats while leaving agent-specific pathology to other sources.

Slide 68 · Primary sources and scope

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. “Agents of Bioterrorism” section.

Additional source-backed context: textbook discussions of anthrax, plague, poxviruses, and viral hemorrhagic fever.

Additional source-backed context: textbook discussion of cholera.

For clinical practice, verify current official recommendations separately from this pathology summary.